Lipocine Inc. (LPCN)
3.01
-0.06 (-1.95%)
At close: Mar 03, 2025, 3:59 PM
3.01
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Lipocine Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | -2.85M | 500K | 16.14M | n/a | 164.99K | 428.03K | n/a | n/a | n/a | n/a | n/a | 7.71M | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M | n/a |
| Gross Profit | -2.85M | 500K | 16.14M | n/a | 164.99K | 428.03K | n/a | n/a | n/a | n/a | n/a | 5.43M | n/a |
| Operating Income | -17.93M | -12.12M | 3.15M | -18M | -12.9M | -11.33M | -21.22M | -18.46M | -18.38M | -20.48M | -8.76M | 3.88M | -5.16K |
| Interest Income | 1.37M | 545.48K | 135.59K | 310.97K | 343.25K | n/a | n/a | n/a | 173.89K | 108.34K | 38.48K | 10.31K | n/a |
| Pretax Income | -16.35M | -10.76M | -634.2K | -20.96M | -13.01M | -11.66M | -20.98M | -18.97M | -18.21M | -20.37M | -10.65M | 3.89M | -5.16K |
| Net Income | -16.35M | -10.76M | -634.4K | -20.96M | -13.01M | -11.66M | -20.98M | -18.97M | -18.21M | -20.37M | -10.59M | 3.8M | -5.16K |
| Selling & General & Admin | 4.9M | 4.06M | 5.33M | 8.25M | 5.6M | 5.29M | 10.21M | 10.38M | 5.8M | 5M | 3.64M | 1.55M | 5K |
| Research & Development | 10.18M | 8.56M | 7.67M | 9.75M | 7.47M | 6.46M | 11M | 8.08M | 12.58M | 15.48M | 5.59M | 3.04M | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 15.08M | 11.8M | 16.64M | 20.65M | 12.83M | 12.09M | 20.98M | 18.97M | 18.38M | 20.48M | 10.68M | 1.55M | 5.16K |
| Interest Expense | n/a | 27.1K | 203.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 15.08M | 11.8M | 16.64M | 20.65M | 12.83M | 12.09M | 20.98M | 18.97M | 18.38M | 20.48M | 10.68M | 3.83M | 5.16K |
| Income Tax | 755.00 | 681.00 | 200.00 | 200.00 | 200.00 | 700.00 | 700.00 | 752.00 | 200.00 | 200.00 | 55.05K | 684.00 | n/a |
| Shares Outstanding (Basic) | 5.27M | 4.99M | 3.3M | 3.25M | 1.52M | 1.25M | 1.18M | 1.07M | 964.94K | 749K | 432.6K | 263.09K | 1.76K |
| Shares Outstanding (Diluted) | 5.27M | 5.26M | 5.15M | 3.28M | 1.52M | 1.26M | 1.18M | 1.07M | 968.87K | 750.96K | 433.12K | 262.1K | 1.76K |
| EPS (Basic) | -3.14 | -2.15 | -0.19 | -6.46 | -8.54 | -9.35 | -17.79 | -17.66 | -18.79 | -27.13 | -24.45 | 14.50 | -2.93 |
| EPS (Diluted) | -3.14 | -2.05 | -0.12 | -6.4 | -8.54 | -9.28 | -17.85 | -17.68 | -18.87 | -27.2 | -24.48 | 14.45 | -2.93 |
| EBITDA | -16.32M | -10.72M | -430.53K | -17.99M | -12.65M | -11.31M | -21.19M | -18.94M | -18.36M | -20.47M | -10.62M | -76.65K | -5.16K |
| Depreciation & Amortization | 28.66K | 9.45K | 380.00 | 3.55K | 15.44K | 18.59K | 28.37K | 31.96K | 26.72K | 14.62K | 21.77K | 42.57K | n/a |